SAUTEBIN, LIDIA
 Distribuzione geografica
Continente #
AS - Asia 5.382
NA - Nord America 5.191
EU - Europa 3.556
SA - Sud America 600
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 105
OC - Oceania 10
Totale 15.064
Nazione #
US - Stati Uniti d'America 4.995
SG - Singapore 2.510
RU - Federazione Russa 1.460
CN - Cina 943
VN - Vietnam 892
HK - Hong Kong 541
BR - Brasile 476
UA - Ucraina 421
IT - Italia 404
FR - Francia 272
DE - Germania 257
FI - Finlandia 218
IE - Irlanda 156
CA - Canada 108
JP - Giappone 91
GB - Regno Unito 84
SE - Svezia 82
IN - India 77
NL - Olanda 77
BD - Bangladesh 48
IQ - Iraq 48
AR - Argentina 39
MX - Messico 36
TR - Turchia 34
TH - Thailandia 28
RS - Serbia 27
ID - Indonesia 25
CI - Costa d'Avorio 24
EC - Ecuador 22
ZA - Sudafrica 22
PH - Filippine 21
PL - Polonia 21
ES - Italia 19
AT - Austria 18
JM - Giamaica 17
VE - Venezuela 16
CO - Colombia 13
PK - Pakistan 12
TW - Taiwan 12
MY - Malesia 10
PY - Paraguay 10
CL - Cile 9
RO - Romania 9
SA - Arabia Saudita 9
KR - Corea 8
UZ - Uzbekistan 8
AU - Australia 7
JO - Giordania 7
MA - Marocco 7
AZ - Azerbaigian 6
BO - Bolivia 6
IL - Israele 6
IR - Iran 6
KE - Kenya 6
PE - Perù 6
BG - Bulgaria 5
LB - Libano 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
EG - Egitto 4
GT - Guatemala 4
HN - Honduras 4
PT - Portogallo 4
UG - Uganda 4
AE - Emirati Arabi Uniti 3
CY - Cipro 3
DZ - Algeria 3
EU - Europa 3
GR - Grecia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LY - Libia 3
NG - Nigeria 3
PS - Palestinian Territory 3
AF - Afghanistan, Repubblica islamica di 2
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
BZ - Belize 2
CD - Congo 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GH - Ghana 2
KH - Cambogia 2
LU - Lussemburgo 2
MD - Moldavia 2
MG - Madagascar 2
MM - Myanmar 2
MN - Mongolia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
SI - Slovenia 2
SO - Somalia 2
TG - Togo 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 14.810
Città #
Singapore 1.095
San Jose 718
Hong Kong 519
Jacksonville 390
Chandler 377
Moscow 341
Santa Clara 275
Beijing 265
Ashburn 228
Ho Chi Minh City 222
Millbury 213
Council Bluffs 194
Hanoi 183
Princeton 180
The Dalles 168
Dong Ket 162
Lauterbourg 150
Los Angeles 110
Nanjing 108
Boston 102
Buffalo 92
Wilmington 87
Tokyo 79
Amsterdam 62
Naples 60
New York 59
Ottawa 54
Roubaix 45
Dallas 44
Nanchang 39
Hebei 36
Redondo Beach 36
São Paulo 36
Woodbridge 36
Munich 34
Orem 33
Seattle 33
Da Nang 31
Shenyang 31
Des Moines 30
Haiphong 30
Norwalk 26
Helsinki 25
Phoenix 25
Tianjin 25
Belgrade 24
Jiaxing 23
Brooklyn 22
Mexico City 20
Nuremberg 20
Rome 20
Chicago 19
Houston 18
Kronberg 18
Milan 18
Napoli 18
Baghdad 17
Chennai 17
Hefei 17
Changsha 15
Hải Dương 14
San Francisco 14
Brasília 13
Denver 12
Falls Church 12
Istanbul 12
Johannesburg 12
Redwood City 12
Rio de Janeiro 12
Turku 12
Warsaw 12
Atlanta 11
Biên Hòa 11
Boardman 11
Kingston 11
London 11
Frankfurt am Main 10
Hangzhou 10
Montreal 10
Orange 10
Tübingen 10
Bangkok 9
Belo Horizonte 9
Florence 9
Indiana 9
Toronto 9
Guangzhou 8
Hanover 8
Miami 8
Ninh Bình 8
Quận Bình Thạnh 8
Campinas 7
Falkenstein 7
Guarulhos 7
Kunming 7
Louisville 7
Quito 7
Stockholm 7
Tashkent 7
Amman 6
Totale 7.763
Nome #
Regulation (EC) No. 1223/2009 on cosmetic products ('Cosmetics Regulation'): the European Cosmetovigilance System. Serious Undesirable Effects Reporting Guidelines and notification Forms 162
Use of Mometasone furoate in prolonged treatment of experimental spinal cord injury in mice: A comparative study of three different glucocorticoids 160
Capitolo 42 del Trattato di Farmacologia. Farmaci per la terapia della gotta 151
5-LIPOXYGENASE KNOCKOUT MICE EXHIBIT A RESISTANCE TO PLEURISY AND LUNG INJURY CAUSED BY CARRAGEENAN. 150
BRP-7, a novel benzimidazole-based chemotype targeting 5-lipoxygenase-activating protein, inhibits leukotriene biosynthesis in experimental models of acute inflammation in vivo. 149
5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration 135
In vivo differences in leukotriene biosynthesis in zymosan-induced peritonitis: role of resident peritoneal macrophages. 135
BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly 134
On the inhibition of 5-lipoxygenase product formation by tryptanthrin: mechanistic studies and efficiency in vivo. 131
The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP). 131
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 129
Myrtucommulone from Myrtus communis: metabolism, permeability, and systemic exposure in rats 127
5-ARYLIDENE-2-IMINO-4-THIAZOLIDINONES: DESIGN AND SYNTHESIS OF NOVEL ANTI-INFLAMMATORY AGENTS. 126
Novel analgesic/anti-inflammatory agents: 1,5-diarylpyrrole nitrooxyalkyl ethers and related compounds as cyclooxygenase-2 inhibiting nitric oxide donors 126
5-LIPOXYGENASE KNOCKOUT MICE EXHIBIT A RESISTANCE TO ACUTE PANCREATITIS INDUCED BY CERULEIN. 125
SAR Studies on Curcumin's Pro-inflammatory Targets: Discovery of Prenylated Pyrazolocurcuminoids as Potent and Selective Novel Inhibitors of 5-Lipoxygenase. 125
SLOW REACTING SUBSTANCE OF ANAPHYLAXIS ENHANCES THE GENERATION OF 12 L HYDROXY 5,8,10,14 EICOSATETRAENOIC ACID IN ISOLATED LUNGS. 123
In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis. 123
1,5-DIARYLPYRROLE-3-ACETIC ACIDS AND ESTERS AS NOVEL CLASSES OF POTENT AND HIGHLY ELECTIVE CYCLOOXYGENASE-2 INHIBITORS. 122
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity 122
Inhibition of inducible Nitric Oxide Synthase expression by an acetonic extract from Feijoa sellowiana Berg. fruits. 119
Anti-inflammatory activity of macrolide antibiotics. 119
IDENTIFICATION AND PARTIAL PURIFICATION OF AN ENDOTHELIAL-DERIVED RELAXING FACTOR(S) IN SERUM OF HYPERTENSIVE PREECLAMPTIC PARTURIENTS. 118
The novel Sinupret® dry extract exhibits anti-inflammatory effectiveness in vivo 117
LEUKOTRIENES IN HUMAN LUNG: FORMATION AND BINDING SITES. 116
ANTINFIAMMATORI NON STEROIDEI 116
EPIDEMIOLOGICAL STUDIES ON DIETARY LIPIDS,HUMAN PLASMA LIPIDS AND PLATELET LIPIDS AND FUNCTION. 115
Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2 115
HYDROGEN SULPHIDE-INDUCED MOUESE PAW EDEMA INVOLVES PHOSPHOLIPASE A2 ACTIVATION 115
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. 115
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme 114
Flow synthesis and biological studies of an analgesic adamantane derivative that inhibits P2X7-evoked glutamate release 113
5-LIPOXYGENASE KNOCKOUT MICE EXHIBIT A RESISTANCE TO SPLANCHNIC ARTERY OCCLUSION SHOCK. 112
ARACHIDONIC ACID METABOLISM AND CYCLIC NUCLEOTIDES IN THE CNS DURING HYPOXIA. 112
Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity. 110
Synthesis and structure-activity of antisense peptides corresponding to the region for CaM-binding domain of the inducible nitric oxide synthase 109
LIPOCORTIN AND VASOCORTIN: TWO SPECIES OF GLUCOCORTICOID INDUCED PROTEINS AFFECTING VASCULAR PERMEABILITY. 109
ROLE OF NITRIC OXIDE ON MULTIPLE ORGANE FAILURE INDUCED BY ZYMOSAN. 108
Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression 107
Hydrogen sulphide-induced mouse paw edema involves phospholipase A2 activation. 106
Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring CholesterolEsterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo. CO-FIRST AUTHOR 105
Oxalomalate affects the inducible nitric oxide synthase expression and activity 104
The role of 5-lipoxygenase and leukotrienes in shock and ischemia-reperfusion injury. 103
HEALING POWER OF ALOES 103
NITRIC OXIDE INHIBITS LEUKOCYTES MIGRATION IN RAT DERMAL PASSIVE ARTHUS REACTION AND CARRAGEENAN PLEURISY. 103
Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. 100
Synthesis of 2-Methyl-3-indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 without Gastric Damage 99
CONVERSION OF ARACHIDONIC ACID BY LIPOXYGENASE AND CYCLOOXYGENASE ACTIVITIES: QUALITATIVE AND QUANTITATIVE ASPECTS. 97
Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. 96
The 5-lipoxygenase inhibitor zileuton inhibits prostaglandin production by reducing arachidonic acid release: in vitro and in vivo effects. 96
Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase 95
Up-regulation of prostaglandin biosynthesis by leukotriene C4 in elicited mice peritoneal macrophages activated with lipopolysaccharide/interferon-gamma 93
17BETA-ESTRADIOL ANTINFLAMMATORY ACTIVITY IN CARRAGEENIN-INDUCED PLEURISY. 91
Healing powers of aloes 91
The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. 90
STIMULUS RELATED DIFFERENCES IN THE FORMATION FORMATION OF LEUKOTRIENES AND PGD2 AFTER IMMUNOLOGICAL AND NON IMMUNOLOGICAL CHALLENGE OF HUMAN LUNG PARENCHIMA "IN VITRO". 89
Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo. 89
“La segnalazione degli eventi indesiderabili secondo il Regolamento (CE) n. 1223/2009: le linee guida e le schede di segnalazione” 89
A MASS FRAGMENTOGRAPHIC PROCEDURE FOR THE SIMULTANEOUS DETERMINATION OF HETE AND PGF2 IN THE CENTRAL NERVOUS SYSTEM. 88
Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males 88
ROLE OF 5-LIPOXYGENASE IN THE MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN. 86
A cosmetovigilance survey in Europe. 86
Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo. 86
Relaxant effect of capsazepine in the isolated rat ileum 85
Inhibition of microsomal prostaglandin E(2) synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense. 85
INVOLVEMENT OF NF-KB IN THE REGULATION OF CYCLOOXIGENASE-2 PROTEIN EXPRESSION IN LPS-STIMULATED J774 MACROPHAGES. 84
PROTECTIVE EFFECTS OF ANTHOCYANINS FROM BLACKBERRY IN A RAT MODEL OF ACUTE LUNG INFLAMMATION. 84
Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase. 84
THE ROLE OF THE PHENETHYLE ESTER OF CAFFEIC ACID ( CAPE) IN THE INHIBITION OF RAT LUNG CYCLOOXYGENASE ACTIVITY BY PROPOLIS. 83
REGULATION OF PROSTAGLANDIN GENERATION IN CARRAGEENAN-INDUCED PLEURISY BY INDUCIBLE NITRIC OXIDE SYNTHASE IN KNOCKOUT MICE 83
EFFECTS OF WATER DEPRIVATION AND ANGIOTENSIN II INTRACEREBROVENTRICULAR ADMINISTRATIONON BRAIN NITRIC OXIDE SYNTHASE ACTIVITY. 82
Effect of methylguanidine, guanidine and structurally related compounds on constitutive and inducible nitric oxide synthase activity 82
Lipocortins 82
Interaction between nitric oxide and prostaglandins in inflammation. 82
ANALYSIS OF CYCLOOXYGENASE AND LIPOXYGENASE PRODUCTS IN INCUBATION MEDIA. 81
EFFECT OF THE B2-ADRENERGIC AGONIST FENOTEROL ON THE RELEASE OF LEUKOTRIENES AND PROSTAGLANDIN D2 FROM HUMAN LUNG PARENCHIMA. 81
PGF2A,THROMBOXANE B2 AND HETE LEVELS IN GERBIL BRAIN CORTEX AFTER LIGATION OF COMMON CAROTID ARTERIES AND DECAPITATION. 81
ANALYTICAL PROCEDURES FOR THE STUDY OF ARACHIDONIC ACID METABOLISM IN PLATELETS AND BRAIN. 81
ARACHIDONIC ACID METABOLISM IN THE LUNGS: EFFECT OF HISTAMINE AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS. 81
PROSTAGLANDINE E OSSIDO D'AZOTO COME BERSAGLI MOLECOLARI PER LA TERAPIA ANTINFIAMMATORIA 81
"I cosmetici contraffatti e il loro impatto sulla sicurezza d’uso e sulla salute dei consumatori. Ruolo della sorveglianza e della vigilanza” 81
Cyclooxygenase-2-dependent generation of 8-epiprostaglandin F2alfa by lipopolysaccharide-activated J774 macrophages. 80
CONGENITAL DEFICIENCY OF THROMBOXANE AND PROSTACYCLIN. 80
THE MODE OF ACTION OF TIARAMIDE HYDROCHLORIDE:A NEW ANTIASTHMATIC DRUG. 80
Analysis of toxic exposures to cosmetic products through the data base of the Poison Control Centre of the Niguarda Ca’ Granda Hospital 80
“Il nuovo sistema di Cosmetovigilanza secondo il Regolamento 1223/2009: le iniziative del Ministero della Salute” 80
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase 80
Cosmetovigilance survey: are cosmetics considered safe by consumers? 79
Cinnamyl-3,4-Dihydroxy-{alpha}-Cyanocinnamate Is a Potent Inhibitor of 5-Lipoxygenase. 79
FOOD DEPRIVATION INCREASES BRAIN NITRIC OXIDE SYNTHASE AN DEPRESSES BRAIN SEROTONIN LEVELS IN RATS. 78
USE OF TRITIUM LABELED AMINO ACID CONJUGATES OF PROSTAGLANDINS AND THROMBOXANE AS LABELED LIGANDS IN PROSTANOID RADIOIMMUNOASSAY. 77
Gender-specific regulation of 5-lipoxygenase 77
Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. 76
Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold 76
RELEASE OF LEUKOTRIENS, INDUCED BY THE CA++-IONOPHORE A23187,FROM HUMAN LUNG PARENCHIMA. 75
2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52) - a novel type 5-lipoxygenase inhibitor with favorable molecular pharmacology and efficacy in vivo. 75
REGULATION OF PROSTAGLANDINS PRODUCTION BY INHIBITION OF POLY(ADP-RIBOSE) SYNTHASE IN CARRAGEENIN-INDUCED PLEURISY. 74
Nitric oxide and prostaglandins in inflammation. 74
The inhibitory effect of propolis and caffeic acid phenethyl ester on cyclooxygenase activity inJ774 macrophages 74
Adverse cosmetic events: a pilot project 73
Totale 10.068
Categoria #
all - tutte 54.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.841


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022954 0 0 6 16 1 35 15 46 172 42 202 419
2022/2023805 235 87 39 41 79 80 0 52 98 57 26 11
2023/2024534 17 87 64 27 17 19 5 64 6 9 163 56
2024/20253.687 243 308 23 31 62 239 436 188 361 383 1.079 334
2025/20266.242 720 421 608 411 1.074 211 726 499 856 450 140 126
2026/2027496 186 166 144 0 0 0 0 0 0 0 0 0
Totale 15.064